INmune Bio Inc Financial Flexibility Index
INmune Bio Inc financial flexibility index. INmune Bio Inc (INMB) has a Financial Flexibility Index of -0.95x as of June 2026. Free cash flow of $-6.15 Million (operating CF $-6.58 Million minus capex $430.00K) represents -1% of total liabilities ($6.48 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of INmune Bio Inc (2015–2025)
Financial flexibility index of INmune Bio Inc from 2015 to 2025. Historical Financial Flexibility Index trend for INmune Bio Inc across 11 annual periods. Check INMB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
INmune Bio Inc Financial Flexibility Index by Year (2015–2025)
INmune Bio Inc financial flexibility index by year from 2015 to 2025. Year-by-year free cash flow to debt coverage for INmune Bio Inc. For the full cash flow conversion analysis, see INmune Bio Inc (INMB) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-21.54 Million | $-22.58 Million | $8.83 Million | ▲ +45.4% |
| 2024 | -4.47x | $-33.36 Million | $-33.36 Million | $7.46 Million | ▼ -603.6% |
| 2023 | -0.64x | $-11.98 Million | $-11.98 Million | $18.86 Million | ▲ +39.3% |
| 2022 | -1.05x | $-22.69 Million | $-22.69 Million | $21.69 Million | ▼ -52.7% |
| 2021 | -0.68x | $-13.50 Million | $-28.50 Million | $19.72 Million | ▲ +85.4% |
| 2020 | -4.70x | $-8.94 Million | $-8.94 Million | $1.90 Million | ▲ +24.9% |
| 2019 | -6.26x | $-5.38 Million | $-5.38 Million | $860.54K | ▼ -150.3% |
| 2018 | -2.50x | $-2.06 Million | $-2.06 Million | $823.77K | ▼ -17.0% |
| 2017 | -2.14x | $-661.83K | $-761.83K | $309.72K | ▼ -304.5% |
| 2016 | -0.53x | $-317.38K | $-317.38K | $600.81K | ▲ +10.3% |
| 2015 | -0.59x | $-18.12K | $-18.12K | $30.75K | — |